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SUMMARY
Background. Video-EEG (VEEG) monitoring is a vital diagnostic tool, but there are no guidelines for with-
drawal of antiepileptic drugs (AEDs).
Aim. The main objectives of this study were to understand the different withdrawal strategies used in the 
EMU, how strategies are chosen, and the efficacy and safety of different withdrawal strategies in produc-
ing seizures.
Materials and methods. We retrospectively analyzed 95 consecutive patients and measured time to first 
seizure, incidence of status epilepticus, and need for rescue medications.
Results. We found that AED withdrawal strategies can be divided into four categories based on level of ag-
gressiveness. The main factors which impacted choice of strategy was number of AEDs on admission and 
frequency of pre-admission seizures. Abrupt cessation of medications was correlated with longer time to 
first seizure compared to other methods (hazard ratio (HR) 0.36, 95% confidence interval (CI) 0.20–0.65, 
p = 0.0007). Patients remaining on medications had shorter time to first seizure (HR 2.98, 95% CI 1.22–7.24, 
p = 0.016). Withdrawal technique was not correlated with need for rescue medications (OR 5.0, 95% CI 
0.77–43, p = 0.20). No patients had status epilepticus in the study.
Conclusions. Pre-admission seizure frequency and number of AEDs are the main factors which drive 
choice of withdrawal strategy on the epilepsy monitoring unit (EMU). Counterintuitively, least aggressive 
strategy is associated with highest risk of seizures. Results of this analysis suggest that disease factors, not 
choice of withdrawal strategy, determine seizure frequency on the EMU.
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lepsy • seizure • medication withdrawal
BACKGROUND
Video-EEG monitoring is a vital diagnostic tool in epi-
lepsy. It is the gold standard in distinguishing epilepsy 
from non-epileptic seizures and is also used in presur-
gical evaluation of drug-resistant epilepsy. Questions 
remain regarding the optimal management of patients 
during VEEG admission. Previous work on duration 
of monitoring found that 3–5 days is average (Nord-
li, 2006; Hupalo et al., 2016). In patients with frequent 
events the majority had a typical event within two days 
(Cox et al., 2017). Monitoring can be used in patients 
with infrequent events, and tapering antiepileptic drugs 
(AEDs) has a beneficial effect on seizure frequency in 
this population (Al Kasab et al., 2016).
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There is little consensus regarding the best AED 
withdrawal regimen during VEEG. A recent survey 
of epilepsy monitoring units (EMUs) revealed 80% of 
centers do not have a protocol for medication taper, 
and withdrawal is generally done on a case by case ba-
sis (Buelow et al., 2009). Guld et al. (2017) compared 
slow and fast AED taper and found higher incidence 
of rescue therapy and increased risk of generalized sei-
zures with rapid taper. Kumar and colleagues (2018) al-
so found increased need for rescue therapies with ta-
per but no increased risk of generalized seizures. Sev-
eral other studies have also suggested that AED with-
drawal is safe and effective but may lead to increased 
risk of acute repetitive seizures (Gennaro et al., 2012; 
Henning et al., 2014; Yen et al., 2001; Rose et al., 2003; 
Rizvi et al., 2014).
AIM
The main objectives of this study were to understand 
the different withdrawal strategies used in the EMU, 
how various strategies are chosen, and the efficacy 
and safety of different withdrawal strategies in pro-
ducing seizures.
MATERIALS AND METHODS
We performed a retrospective observational study of 
adult patients with a diagnosis of focal epilepsy under-
going scalp or intracranial monitoring at Dartmouth 
Hitchcock Medical Center from 2015 to 2016. Lack of 
epileptic seizures during admission or length of stay 
greater than 29 days were exclusion criteria. Variables 
recorded were age, gender, AEDs, self-reported outpa-
tient seizure frequency, use of rescue medications dur-
ing admission, withdrawal method, occurrence of sta-
tus epilepticus, number of days in the monitoring unit, 
and duration of epilepsy. The data was analyzed using 
cox regression plots, hazard ratios and T tables.
One limitation of our methods was our inability to 
capture the nature and severity of patient’s epilepsy. 
The use of Kaplan-Meier plots and multivariable Cox 
regression models attempted to capture the variables 
associated with time to first seizure and need for res-
cue medications but could not capture the efficacy of 
the monitoring itself with respect to whether all sei-
zure types were seen and the severity of those seizures.
RESULTS
The demographics of our population are illustrated in 
Table 1. All patients had focal epilepsy with temporal 
and extra temporal localization approximately equal.
Based on time and number of medications stopped, 
we found that withdrawal methods can be separated 
into four categories: remaining on AEDs (least aggres-
sive), cutting doses of AEDs gradually, stopping med-
ications one-by-one, and abrupt cessation of all medi-
cations (most aggressive). The most common weaning 
strategy was stopping medications one by one (n = 57), 
with other strategies used less frequently (Table 1).
Table 1. Demographics
Gender Male 47 (49.5%) Female 48 (50.5%)
Type of epilepsy Temporal 49 (51.6%) Extra-temporal 46 (48.4%)
Length of stay Mean 3.57 days Range 3–16 days
Age Mean 43.3 years Range 21–85 years
Weaning strategy Remain on medications n =  6
Cutting doses n = 12
Stop one by one n = 57
Abrupt cessation n = 20
Table 2. Factors associated with time to first seizure: abrupt cessation of medications was 
used as a reference, this was compared to other withdrawal methods
Time to first seizure Hazard ratio (95%CI) p-value
Years of seizures 0.99 (0.98–1.01) 0.42
Seizure frequency 1.00 (0.99–1.00) 0.38
Abrupt cessation 1.0 (reference)
Cut doses 1.67 (0.74–3.77) 0.22
Stop one-by-one 2.79 (1.53–5.09) 0.00084
Remain on medications 7.01 (2.46–20) 0.00027
17Withdrawal strategy in the EMU
Factors associated with choice of weaning strate-
gy are shown in Table 2. The main factors associated 
with choice of weaning strategy were number of AEDs 
at the time of admission (p = 0.0044) and frequency of 
seizures per month (p = 0.00036) (Figure 1). Self-re-
ported frequency of seizures was not associated with 
time to first seizure. Years of seizures and frequency 
of seizures were not associated with the need for res-
cue medications.
Figure 2 shows time to first seizure for each wean-
ing strategy using a cox-regression analysis adjusted for 
length of epilepsy and outpatient seizure frequency. Pa-
Figure 1. Remaining on medications was significantly associated with higher 
frequency of seizures per month compared to other groups (p = 0.00036).
Figure 2.  Time to first seizure by weaning technique: Cox regression used to 
calculate p-values comparing the seizure free proportion for weaning method to 
the others with adjustment for years of seizures and frequency of seizures per 
month.
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tients with abrupt cessation of medications had longer 
time to first seizure compared to other methods (haz-
ard ratio (HR) 0.36, 95% confidence interval (CI) 0.20–
0.65, p = 0.0007). Patients with one-by-one stopping 
strategy had shorter time to first seizure compared to 
other groups (HR 1.73, 95% CI 1.09–2.75, p = 0.02). Pa-
tients remaining on medications also had shorter time 
to first seizure (HR 2.98, 95% CI 1.22–7.24, p = 0.016). 
There was no difference between cutting doses or stop-
ping one-by-one (p = 0.43).
There were no episodes of status epilepticus in the 
study. Weaning technique was not associated with need 
for rescue medications (OR 5.0, 95% CI 0.77–43, p = 0.20). 
There was a significant correlation with number of out-
patient seizure medications and need for rescue medi-
cines (p = 0.045 when comparing 1 AED vs 2–3 AEDs).
DISCUSSION
Previous work has shown that VEEG with medication 
taper yields diagnosis in 75–88% of epilepsy and non-
epileptic seizures (Moien-Afshari et al., 2009; Lobello 
et al., 2006). Physicians responsible for patients in the 
EMU are therefore tasked with deciding on an appro-
priate medication taper plan. This plan must balance 
the need for induction of seizures with the necessity to 
maximize safety and minimize the risk of status epi-
lepticus or injury. For this purpose, AED taper plans of 
various aggressiveness have been developed.
At our institution we use four distinct taper plans 
which range from keeping patients on medications to 
abrupt discontinuation. These varying strategies at-
tempt to maximize benefit of reduced time to first sei-
zure and minimize risk of acute repetitive seizures 
and status epilepticus. We found that the key driv-
ers of withdrawal strategy are the number of seizures 
per month and the number of AEDs taken in the out-
patient setting. Patients with a higher number of sei-
zures per month were more likely to have a conserva-
tive medication taper.
Disease factors, not withdrawal strategy influence 
time to first seizure in the EMU. Our findings are con-
trary to previous studies which showed a correlation 
between rapid AED titration and increased seizure 
frequency in the EMU (Al Kasab et al., 2016), and are 
more consistent with the previous finding that AED ta-
per rates do not affect daily seizure frequency in EMU 
(Henning et al., 2014).
Our work also confirms previous reports which 
demonstrated that tapering medications in the EMU 
is safe. First, we found that the risk of status epilepti-
cus is very low, confirming previous studies (Rose et al., 
2003). Second, we found that patients with medication 
discontinuation do not have higher risk of acute repet-
itive seizures or seizure clusters, applying the need for 
rescue medications as a surrogate for this. A recent ran-
domized controlled trial compared rapid versus slow 
medication weaning in pediatric and adult patients 
with drug resistant epilepsy. Time to first seizure and 
seizure clusters were increased in the rapid taper group 
(Kumar et al., 2018). Our contrasting results may be ac-
counted for by different patient populations.
The limitations of our study are that it is nonrand-
omized and retrospective. Because of this, the results 
should not be taken to suggest that choice of specific 
weaning strategy has no influence on seizure frequen-
cy or safety in the EMU. Evidence from this study sup-
ports the idea that weaning approach should be tailored 
to the individual patient. Another limitation is that we 
included only patients with focal epilepsy, so findings 
may not be generalizable to patients with nonepileptic 
events or generalized epilepsies. Most groups were well 
powered but the group which remained on medications 
only had 6 participants so conclusions may be limited 
by that sample size. Last, previous work has shown that 
patient self-reporting of seizures may be unreliable, es-
pecially for focal epilepsy (Blum et al., 1996).
CONCLUSIONS
Disease factors determine medication withdrawal 
strategy in the EMU and influence time to first sei-
zure. Clinicians should tailor their weaning approach 
to the individual patient. Medication taper is safe with 
low risk for status epilepticus and acute repetitive sei-
zures. These findings should be confirmed with a large, 
prospective study in adult patients with focal epilepsy.
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